Yesterday, I linked an article written by Michael Fumento, which noted that a potential cure for juvenile diabetes using adult stem cells is not being funded by the Juvenile Diabetes Research Foundation, even though the technique cured mice with late stage disease.
Fumento wanted to follow up with a “Part 2” commentary. But, it appears that somebody doesn’t want this truth widely disseminated. According to Fumento, his syndicate, Scripps Howard refused to publish the article, based on it allegedly being a “diatribe.” What? Fumento’s tone is utterly reasonable. The facts about which he opines are indisputable. Indeed, SCIENCE DID publish the study demonstrating that adult spleen stem cells completely cured mice with late stage juv. diabetes. Despite this amazing success, the JDRF DID refuse to fund human trials. Finally, the JDRF DID fund Proposition 71, which created a right to therapeutic cloning, to the tune of about $2 million. Yet, even IF that technology EVER becomes an effective treatment for juv. diabetes, it is at least a decade or more away.
This raises an important question: Is the JDRF most interested in finding a cure for juvenile diabetes or in promoting embryonic stem cell research and therapeutic human cloning? Surely, this is a topic worthy of being explored by a knowledgeable pundit. And if so, why the censorship?
Comments are visible to subscribers only. Log in or subscribe to join the conversation.
